Frankfurt - Delayed Quote EUR
Thiogenesis Therapeutics, Corp. (Q8M.F)
0.3840
-0.0260
(-6.34%)
At close: May 2 at 9:59:02 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
2/28/2022
12/31/2021
Operating Cash Flow
-4,078.6060
-3,248.4630
-2,089.6930
-67.0760
-768.1300
Investing Cash Flow
--
--
107.4570
--
--
Financing Cash Flow
4,590.7260
4,121.2260
8,126.6310
3,326.7580
818.5150
End Cash Position
4,143.7360
7,076.3080
6,195.9610
3,406.1130
62.5490
Issuance of Capital Stock
--
4,121.2260
4,879.9700
--
674.8130
Issuance of Debt
--
--
--
--
143.7020
Repayment of Debt
--
--
-175.1720
--
--
Free Cash Flow
-4,078.6060
-3,248.4630
-2,089.6930
-67.0760
-768.1300
12/31/2021 - 2/24/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NEUP Neuphoria Therapeutics Inc.
5.06
+1.10%
PMVP PMV Pharmaceuticals, Inc.
0.9966
-0.34%
EPIX ESSA Pharma Inc.
1.7300
-2.26%
IKNA Ikena Oncology, Inc.
1.2500
+2.46%
HLVX HilleVax, Inc.
1.9600
+1.55%
ATXS Astria Therapeutics, Inc.
5.36
+3.88%
KZR Kezar Life Sciences, Inc.
4.5000
+2.27%
GLTO Galecto, Inc.
2.9900
-1.64%
NERV Minerva Neurosciences, Inc.
1.7000
-2.30%
ANTX AN2 Therapeutics, Inc.
1.2200
-1.61%